Drugs / ASP2246
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07318714 | Apr 2026 → Feb 2030 expected | ischemic stroke | Astellas Pharma Inc | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP2246 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07318714 ↗ |
| Route | Other | “Intracerebral parenchymal infusion via SmartFlow Neuro cannula.” NCT07318714 ↗ |